Connect Biopharma Holdings Ltd
Related Filers (13)
- RA CAPITAL MANAGEMENT, L.P. (5)
- RA Capital Nexus Fund, L.P. (4)
- RA Capital Healthcare Fund LP (4)
- BioFortune Inc (3)
- Wei Zheng (3)
- FMR LLC (2)
- Huang James (2)
- Deutsche Bank Trust Co Americas/ ADR Group (1)
- Qiming Venture Partners VII, L.P. (1)
- Advantech Capital II L.P. (1)
- Shanghai Minhui Enterprise Management Consulting Partnership (Limited Partnership) (1)
- Qiming Venture Partners V, L.P. (1)
- Panacea Innovation Ltd (1)
- Show More ...
Other (75)
6-K
Monday, 2/12/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 12/18/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 12/18/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 12/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 11/27/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 11/27/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 11/21/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 11/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 11/21/2023
Filing for proposed sale of securities under Rule 144
6-K
Wednesday, 11/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Monday, 7/24/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Friday, 7/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 4/11/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 3/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 7/6/2022
Notice of Effectiveness
CORRESP
Friday, 7/1/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 6/17/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3/A
Friday, 6/17/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Friday, 6/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3/A
Monday, 5/23/2022
Registration statement for specified transactions by certain foreign private issuers
CORRESP
Friday, 5/20/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 5/9/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/5/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Friday, 4/15/2022
Registration statement for specified transactions by certain foreign private issuers
20-F
Thursday, 3/31/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/5/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/19/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/19/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/8/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/2/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/31/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/27/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/17/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/11/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CERT
Friday, 3/19/2021
Certification by an exchange approving securities for listing
F-1/A
Thursday, 3/18/2021
Registration statement for securities of certain foreign private issuers
F-1MEF
Thursday, 3/18/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form F-1
EFFECT
Thursday, 3/18/2021
Notice of Effectiveness
EFFECT
Thursday, 3/18/2021
Notice of Effectiveness
CORRESP
Wednesday, 3/17/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Wednesday, 3/17/2021
Registration statement for securities of certain foreign private issuers
CORRESP
Tuesday, 3/16/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 3/16/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Friday, 3/12/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
F-1/A
Friday, 3/12/2021
Registration statement for securities of certain foreign private issuers
F-6
Friday, 3/12/2021
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
CORRESP
Tuesday, 3/9/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 3/8/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Friday, 2/26/2021
Registration statement for securities of certain foreign private issuers
Ownership (20)
SC 13D
Tuesday, 2/13/2024
Panacea Innovation Ltd: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
BioFortune Inc: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Wei Zheng: Major Shareholders
SC 13D/A
Wednesday, 12/20/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13D/A
Thursday, 12/14/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13D/A
Monday, 12/4/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Wednesday, 10/4/2023
Huang James: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Qiming Venture Partners V, L.P.: Major Shareholders
SC 13G
Monday, 2/13/2023
Shanghai Minhui Enterprise Management Consulting Partnership (Limited Partnership): Major Shareholders
SC 13G/A
Monday, 2/13/2023
BioFortune Inc: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Wei Zheng: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
FMR LLC: Major Shareholders
SC 13G
Tuesday, 1/3/2023
Huang James: Major Shareholders
SC 13G
Friday, 2/25/2022
Wei Zheng: Major Shareholders
SC 13G
Friday, 2/25/2022
BioFortune Inc: Major Shareholders
SC 13G
Tuesday, 2/15/2022
Advantech Capital II L.P.: Major Shareholders
SC 13G
Monday, 2/14/2022
Qiming Venture Partners VII, L.P.: Major Shareholders
SC 13G
Wednesday, 2/9/2022
FMR LLC: Major Shareholders
SC 13D/A
Monday, 6/7/2021
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13D
Monday, 3/29/2021
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
Prospectus (9)
S-8
Friday, 7/1/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Friday, 3/19/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 3/19/2021
Prospectus filed pursuant to Rule 424(b)(4)
DRSLTR
Tuesday, 2/16/2021
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 2/16/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 1/26/2021
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 1/26/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Thursday, 12/17/2020
Correspondence Related to Draft Registration Statement
DRS
Thursday, 12/17/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy